Fulcrum Asset Management LLP Zoetis Inc. Transaction History

Fulcrum Asset Management LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$145.54 - $178.83 $3.76 Million - $4.63 Million	-25,863 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$181.39 - $234.03 $2.68 Million - $3.45 Million	14,758 Added 132.9%	25,863 $4.87 Million
Q3 2021 Oct 19, 2021	BUY	$189.29 - $209.69 $2.1 Million - $2.33 Million	11,105 New	11,105 $1.99 Million
Q2 2021 Jul 12, 2021	SELL	$155.9 - $187.99 $1.45 Million - $1.75 Million	-9,329 Closed	0 $7.76 Million
Q1 2021 Apr 21, 2021	SELL	$144.0 - $169.39 $6.72 Million - $7.91 Million	-46,670 Reduced 83.34%	9,329 $1.34 Million
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $8.8 Million - $9.76 Million	55,999 New	55,999 $8.08 Million
Q3 2020 Oct 21, 2020	SELL	$137.1 - $165.37 $7.68 Million - $9.26 Million	-55,999 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$111.92 - $142.53 $6.27 Million - $7.98 Million	55,999 New	55,999 $8.08 Million

1,947

426M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Fulcrum Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Fulcrum Asset Management LLP with notifications on news.